A case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations

Journal of Rheumatology

Volumn 42, Issue 8, 2015, Pages 1532-1534

  Batu, Ezgi Deniz ^a   Karadag, Omer ^b   Taskiran, Ekim Zihni ^b   Kalyoncu, Umut ^b   Aksentijevich, Ivona ^c   Alikasifoglu, Mehmet ^d   Özen, Seza ^b  

^a Department of Physical Medicine and Rehabilitation   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d Department of Medical Genetics ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETANERCEPT; FRESH FROZEN PLASMA; ILOPROST; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLATE MOFETIL; NONSTEROID ANTIINFLAMMATORY AGENT; TOCILIZUMAB; TUMOR NECROSIS FACTOR INHIBITOR; ADENOSINE DEAMINASE;

ABDOMINAL PAIN; ADENOSINE DEAMINASE 2 DEFICIENCY; ADENOSINE DEAMINASE DEFICIENCY; ADOLESCENT; ADULT; ANEURYSM; BIRMINGHAM VASCULITIS ACTIVITY SCORE; BLOOD ANALYSIS; BONE MARROW BIOPSY; CASE STUDY; CECR1 GENE; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; FEMALE; FEVER; FINGER ULCER; FOCAL GLOMERULOSCLEROSIS; GENE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; ILEOSTOMY; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE PERFORATION; INTESTINE RESECTION; KIDNEY AMYLOIDOSIS; LETTER; MALE; MYELOFIBROSIS; NECROTIZING ARTERITIS; PLASMA TRANSFUSION; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; SCHOOL CHILD; SKIN BIOPSY; TREATMENT RESPONSE; TUBERCULOSIS; YOUNG ADULT; CASE REPORT; DEFICIENCY; GENETIC ASSOCIATION STUDY; GENOTYPE; PHENOTYPE; PRESCHOOL CHILD;

ADENOSINE DEAMINASE; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; PHENOTYPE;

EID: 84940705734     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.150024     Document Type: Letter

References (12)

1. Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 2014;370:921-31.
2. Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 2014;370:911-20.
3. Garg N, Kasapcopur O, Foster J 2nd, Barut K, Tekin A, Kizilkiliç O, et al. Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy. Eur J Pediatr 2014;173:827-30.
4. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65:1-11.
5. Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088-93.
6. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al; Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 2010;69:798-806.
7. Bras J, Guerreiro R, Santo GC. Mutant ADA2 in vasculopathies. N Engl J Med 2014;371:478-80.
8. Kastner DL, Zhou Q, Aksentijevich I. Mutant ADA2 in vasculopathies. N Engl J Med 2014;371:480-1.
9. Segel R, King MC, Levy-Lahad E. Mutant ADA2 in vasculopathies. N Engl J Med 2014;371:481.
10. Van Eyck L, Liston A, Meyts I. Mutant ADA2 in vasculopathies. N Engl J Med 2014;371:478-9.
11. Van Eyck L, Liston A, Wouters C. Mutant ADA2 in vasculopathies. N Engl J Med 2014;371:480.
12. van Montfrans J, Zavialov A, Zhou Q. Mutant ADA2 in vasculopathies. N Engl J Med 2014;371:478.